Table 4. Univariate Kaplan–Meier survival analysis: median overall and progression-free survival time of patients with invasive ovarian carcinoma in different age groups in dependence of LPAAT-β expression.

Characteristic	No. of cases	Median survival time (months)	Standard error	Log-rank P-value
Overall survival
Age <60
LPAAT-β expression
Negative	17	Not reached	—
Positve	28	41.5	6.9	0.024
Age >60
LPAAT-β expression
Negative	9	17.9	1.6
Positive	22	35.5	15.2	0.29
Progression-free survival
Age < 60
LPAAT-β expression
Negative	14	Not reached	—
Positve	18	21.3	14.2	0.012
Age >60
LPAAT-β expression
Negative	7	17.6	4.8
Positive	12	29.8	7.5	0.28